Related Experiment Videos
c-myc Suppression in Burkitt's lymphoma cells
Tomas Simonsson1, Marie Henriksson
1Department of Molecular Biotechnology, Lunfberg Laboratory, Chalmers University of Technology, P.O. Box 462, SE 405 30 Göteborg, Sweden. tomas@mrc-lmb.cam.ac.uk
Biochemical and Biophysical Research Communications
|January 10, 2002
Summary
DNA tetraplex oligonucleotides suppress human c-myc gene expression by inhibiting transcription initiation. This study shows these G-quadruplex forming molecules reduce cancer cell growth.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- The human c-myc gene is a proto-oncogene frequently dysregulated in various cancers.
- Transcription initiation is a critical regulatory step for gene expression.
- DNA secondary structures like G-quadruplexes are increasingly recognized for their roles in gene regulation.
Purpose of the Study:
- To investigate the mechanism by which DNA tetraplex (G-quadruplex)-forming oligonucleotides suppress human c-myc gene transcription initiation.
- To evaluate the effect of these oligonucleotides on cancer cell growth.
Main Methods:
- Administration of a guanine-rich, 22-base oligonucleotide designed to form an intrastrand DNA tetraplex.
- Treatment of a Burkitt's lymphoma cell line with a translocated c-myc allele.
- Assessment of cellular uptake, growth rate, and c-myc expression levels.
Main Results:
- Efficient cellular uptake of the DNA tetraplex oligonucleotide at nanomolar concentrations.
- Significant, concentration- and conformation-dependent inhibition of cancer cell growth.
- Evidence suggests suppression of c-myc gene expression.
Conclusions:
- DNA tetraplex-forming oligonucleotides can effectively suppress human c-myc gene expression.
- These oligonucleotides show potential as therapeutic agents by inhibiting cancer cell proliferation.
- The study provides insights into the molecular mechanisms of c-myc regulation by G-quadruplex structures.